Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Dembinska O, Rojas LM, Chemtob S, Lachapelle P 2002 Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43: 2481–2490
Sennlaub F, Courtois Y, Goureau O 2001 Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest 107: 717–725
Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S 2000 Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res 47: 489–509
Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E 1995 Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024–1028
Shih SC, Ju M, Liu N, Smith LE 2003 Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 112: 50–57
Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO 2003 Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22: 1–29
Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG 2001 Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575–583
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sennlaub, F., Chemtob, S. VEGFR-1: A Safe Target for Prophylaxis of Retinopathy of Prematurity?. Pediatr Res 55, 1–2 (2004). https://doi.org/10.1203/01.PDR.0000108691.21824.E5
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000108691.21824.E5
This article is cited by
-
The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity
Graefe's Archive for Clinical and Experimental Ophthalmology (2008)